CORRECTING and REPLACING Mead Johnson Nutrition Reports Second Quarter Earnings

  CORRECTING and REPLACING Mead Johnson Nutrition Reports Second Quarter
  Earnings

CORRECTION…by Mead Johnson Nutrition Company

Business Wire

GLENVIEW, Ill. -- July 25, 2013

In the Consolidated Statements of Cash Flow table the date should read June 30
(sted March 31).

The corrected release reads:

MEAD JOHNSON NUTRITION REPORTS SECOND QUARTER EARNINGS

Mead Johnson Nutrition Company (NYSE: MJN) today announced its financial
results for the quarter ended June 30, 2013.

  *Sales of $1,055 million for the second quarter of 2013 increased four
    percent on both a reported and constant dollar basis, up from $1,012
    million in the prior-year quarter. Sales growth was eight percent in the
    Asia/Latin America segment, partially offset by a four percent decline in
    the North America/Europe segment due to the impact of businesses exited in
    late 2012.
  *Excluding the impact of non-core businesses exited in late 2012, sales
    growth in the second quarter of 2013 was five percent compared to the same
    quarter a year ago. On the same basis, sales for the North America/Europe
    segment, which included most of the non-core businesses, were in line with
    the prior-year quarter.
  *GAAP net earnings in the second quarter of 2013 were $0.80 per diluted
    share, compared to $0.81 per diluted share a year ago.
  *Non-GAAP ^(1) net earnings were $0.84 per diluted share for the second
    quarter of 2013, compared to $0.83 in the prior-year quarter, driven by
    higher sales and gross margin, with these benefits largely offset by
    higher demand-generation investments.
  *Mead Johnson expects its full-year non-GAAP EPS to be in the range of
    $3.22 to $3.30. Absent any incremental impact related to the China
    antitrust review, we expect GAAP EPS in the range of $3.16 to $3.24.

    ^(1) For the definition of Specified Items and a reconciliation of GAAP
    and non-GAAP results, see “Non-GAAP Financial Measures” on the schedule
    titled “Supplemental Financial Information,” included in this release.

“We are encouraged by our revenue growth in the quarter. It allowed us to
increase demand-generation investments,” said Chief Executive Officer Peter
Kasper Jakobsen. “Our China/Hong Kong business has returned to positive volume
growth after three consecutive quarters of decline. We are fully cooperating
with the Chinese regulatory authorities in the ongoing probe. We expect to
meet with them again in the near future with the objective of reaching a final
resolution. We remain confident in our long-term prospects in this important
market. Sales growth was strong across South Asia and Latin America, with a
majority of markets showing increases in market share. In the North
America/Europe segment, we saw higher non-WIC* market share in the U.S.
offsetting lower category consumption. Importantly, we made significantly
higher investments in demand generation throughout our global operations in
order to drive future growth.”

*WIC=United States Department of Agriculture Special Supplemental Nutrition
Program for Women, Infants, and Children

Second Quarter Results

Sales for the second quarter of 2013 totaled $1,055.3 million, up four percent
from $1,012.3 million in the prior-year period. Price and volume each
contributed two percent to sales growth. Earnings before interest and income
taxes (“EBIT”) totaled $231.6 million compared to $248.3 million in the
prior-year quarter. EBIT in prior-year quarter benefited from significant
transaction gains related to foreign exchange. The second quarter EBIT
declined despite higher sales and gross margins, as we expanded investment in
demand creation. Advertising and promotion spending rose to 16 percent of
sales.

Gross margin for the second quarter of 2013 was 63.6 percent, up from 63.2
percent in the second quarter of 2012. The improvement was mainly in the North
America/Europe segment.

Net earnings attributable to shareholders totaled $162.2 million, or $0.80 per
diluted share, in the second quarter of 2013, compared to $165.8 million, or
$0.81 per diluted share, in the prior-year quarter. The effective tax rate
(“ETR”) was 25.3 percent in the second quarter, compared to 25.9 percent a
year ago. The lower ETR was primarily attributable to management's assertion
that certain current-year foreign earnings and profits are permanently
invested abroad.

On a non-GAAP basis, which excludes Specified Items, net earnings attributable
to shareholders totaled $171.0 million, or $0.84 per diluted share, for the
second quarter of 2013, compared to $171.2 million, or $0.83 per diluted
share, for the same quarter a year ago.

Second Quarter Segment Results

The Asia/Latin America segment reported sales of $757.4 million for the second
quarter of 2013, up eight percent from $702.0 million in the second quarter of
2012. Sales increased six percent from volume and two percent from price.
Price increases in Venezuela and Argentina helped mitigate high inflation in
these markets and accounted for 2% of the segment's growth and 1% of the total
company growth. Category growth combined with higher market share drove the
increase in sales volume. Compared to prior year, China sales volume
increased, after three quarters of decline. Sales volume also increased in
Hong Kong versus the second quarter of 2012, but was down relative to the
first quarter of 2013, as the impact of new export restrictions became more
evident. EBIT for the Asia/Latin America segment totaled $239.6 million in the
second quarter of 2013, compared to $239.9 million for the same quarter a year
ago. The benefit from higher sales was offset by lower gross margins from
country mix and increased investment in demand generation.

The North America/Europe segment reported sales of $297.9 million for the
second quarter of 2013, down four percent from $310.3 million in the second
quarter of 2012. Sales declined six percent from volume offset by a two
percent increase in price. Excluding the impact of exiting several non-core
businesses in 2012, sales were in line with the prior-year quarter. Category
consumption continued to decline in the United States, somewhat offsetting
gains in U.S. non-WIC market share and share gains in Canada. EBIT for the
North America/Europe segment totaled $73.4 million in the second quarter of
2013, up three percent from $72.2 million in the second quarter a year ago.
The EBIT increase was driven by improved gross margins from lower commodity
costs, productivity and price increases in the United States.

Corporate and Other expenses showed an increase primarily due to transaction
gains related to foreign exchange in the prior-year quarter.

Six-Month Results

Sales for the six months ended June 30, 2013 totaled $2,093.2 million, up five
percent from $1,998.9 million a year ago. Sales increased four percent from
price and one percent from volume.

Gross margin improved 30 basis points in 2013 versus the first half of the
prior year. The increase was driven by lower dairy costs and productivity
gains mainly in the North America/Europe segment.

EBIT for the first six months of 2013 totaled $480.7 million, down from $497.1
million in the same period of the prior year. In the first half of 2013, as
compared to the prior-year period, higher sales and improved gross margins
were offset by higher demand-generation investments, transaction gains related
to foreign exchange seen in the prior year, and higher pension settlement
expense.

The effective tax rate for the first half of 2013 was 25.5 percent versus 26.7
percent a year ago. The lower ETR was primarily attributable to management's
assertion that certain current-year foreign earnings and profits are
permanently invested abroad.

Net earnings attributable to shareholders for the first six months of 2013
totaled $334.7 million, or $1.64 per diluted share, compared to $330.0
million, or $1.61 per diluted share, for the same prior-year period.

On a non-GAAP basis, which excludes Specified Items, net earnings attributable
to shareholders totaled $345.0 million, or $1.69 per diluted share, in the
first half of 2013, compared to $338.6 million, or $1.65 per diluted share, in
the first half of 2012.

Six-Month Segment Results

Sales in the Asia/Latin America segment for the first six months of 2013 were
$1,512.7 million, up seven percent from $1,409.3 million in the first half of
2012. Sales increased four percent from price and three percent from volume.
Price increases in Venezuela and Argentina helped mitigate high inflation in
these markets and accounted for 2% of the segment's growth and 1% of the total
company growth. Despite volume declines in China due to a tough 2012
comparable, share gains in many markets and continued category growth drove
volume expansion for the segment. EBIT for the segment totaled $508.0 million
in the first six months of 2013, compared to $520.8 million in the year-ago
period. The EBIT decline was driven by higher demand-generation investments.

The North America/Europe segment reported sales of $580.5 million for the
first six months of 2013, down two percent from $589.6 million in the first
half of 2012. Sales declined five percent from volume, offset by a three
percent increase in price. Excluding the impact of several non-core businesses
exited in late 2012, sales grew by two percent, as price and share gains, both
in our U.S. non-WIC and Canada businesses, more than offset lower category
consumption in the United States. EBIT totaled $124.7 million for the first
six months of 2013, up 20 percent from $104.0 million in the same period of
the prior year. The EBIT improvement was driven by favorable gross margins
from pricing gains, productivity and lower dairy costs.

Corporate and Other expenses showed an increase primarily due to transaction
gains related to foreign exchange in the prior-year quarter.

Outlook for 2013

“We expect to deliver constant-dollar sales growth of about eight percent from
core operations,” Mr. Jakobsen said. “We anticipate growth across our global
portfolio will offset any sales impact from recent price decreases in China.
We will continue to invest in demand generation where we see opportunities to
accelerate growth.” Mead Johnson expects reported sales growth of six percent.
This reflects a two percent impact from discontinued non-core businesses and a
strengthening U.S. dollar. Absent any incremental impact related to the China
antitrust review, GAAP EPS is expected in the range of $3.16 to $3.24. The
Company confirms full-year non-GAAP EPS guidance in the range of $3.22 to
$3.30.

Conference Call Scheduled

Mead Johnson will host a conference call at 8:30 a.m. CDT today, during which
company executives will review second quarter and first-half 2013 financial
results and respond to questions from analysts and investors. The call will be
broadcast over the Internet at www.meadjohnson.com. To listen to the call,
visit the website at least 15 minutes before the call and click on the
“Investors” tab. Security analysts and investors wishing to participate by
telephone should call (866) 515-2907, pass code: Mead Johnson.Callers outside
of North America should call +1-617-399-5121 to be connected. A replay of the
conference call will be available through midnight CDT Thursday, August 1,
2013, by calling (888) 286-8010 or outside of North America +1-617-801-6888,
pass code: 39101758. The replay will also be available at www.meadjohnson.com.

Forward-Looking Statements

Certain statements in this news release are forward-looking as defined in the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements may be identified by the fact they use words such as “should,”
“expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,”
“intend,” “plan,” “believe” and other words and terms of similar meaning and
expression. Such statements are likely to relate to, among other things, a
discussion of goals, plans and projections regarding financial position,
results of operations, cash flows, market position, product development,
product approvals, sales efforts, expenses, capital expenditures, performance
or results of current and anticipated products and the outcome of
contingencies such as legal proceedings and financial results. Forward-looking
statements can also be identified by the fact that they do not relate strictly
to historical or current facts. Such forward-looking statements are based on
current expectations that involve inherent risks, uncertainties and
assumptions that may cause actual results to differ materially from
expectations as of the date of this news release. These risks include, but are
not limited to: (1) the ability to sustain brand strength, particularly the
Enfa family of brands; (2) the effect on the company’s reputation of real or
perceived quality issues; (3) the effect of regulatory restrictions related to
the company's products; (4) the adverse effect of commodity costs; (5)
increased competition from branded, private label, store and economy-branded
products; (6) the effect of an economic downturn on consumers’ purchasing
behavior and customers’ ability to pay for product; (7) inventory reductions
by customers; (8) the adverse effect of changes in foreign currency exchange
rates; (9) the effect of changes in economic, political and social conditions
in the markets where we operate; (10) changing consumer preferences; (11) the
possibility of changes in the WIC program, or participation in WIC; (12)
legislative, regulatory or judicial action that may adversely affect the
company’s ability to advertise its products or maintain product margins; and
(13) the ability to develop and market new, innovative products. For
additional information regarding these and other factors, see the company’s
filings with the United States Securities and Exchange Commission (the “SEC”),
including its most recent Annual Report on Form 10-K, which filings are
available upon request from the SEC or at www.meadjohnson.com. The company
cautions readers not to place undue reliance on any forward-looking
statements, which speak only as of the date made. The company undertakes no
obligation to publicly update any forward-looking statement, whether as a
result of new information, future events or otherwise.

About Mead Johnson

Mead Johnson, a global leader in pediatric nutrition, develops, manufactures,
markets and distributes more than 70 products in over 50 markets worldwide.
The company's mission is to nourish the world’s children for the best start in
life.The Mead Johnson name has been associated with science-based pediatric
nutrition products for over 100 years. The company’s “Enfa” family of brands,
including Enfamil^® infant formula, is the world's leading brand franchise in
pediatric nutrition. For more information, go to www.meadjohnson.com.

                                                  
                                                     
                                                     
MEAD JOHNSON NUTRITION COMPANY

CONSOLIDATED STATEMENTS OF EARNINGS

(Dollars and shares in millions, except per share data)

(UNAUDITED)
                                                     
                       Three Months Ended June 30,   Six Months Ended June 30,
                       2013           2012          2013           2012
NET SALES              $  1,055.3      $ 1,012.3     $  2,093.2      $ 1,998.9
Cost of Products       384.4          372.3        775.3          745.8
Sold
GROSS PROFIT           670.9           640.0         1,317.9         1,253.1
Expenses:
Selling, General and   227.2           221.1         444.2           431.5
Administrative
Advertising and        167.6           148.7         312.1           274.5
Promotion
Research and           25.5            23.6          49.7            46.1
Development
Other
Expenses/(Income) –    19.0           (1.7      )   31.2           3.9
net
EARNINGS BEFORE
INTEREST AND INCOME    231.6           248.3         480.7           497.1
TAXES
                                                                     
Interest Expense –     12.4           17.6         26.6           32.1
net
EARNINGS BEFORE        219.2           230.7         454.1           465.0
INCOME TAXES
                                                                     
Provision for Income   55.6           59.6         116.0          124.1
Taxes
NET EARNINGS           163.6           171.1         338.1           340.9
Less Net Earnings
Attributable to        1.4            5.3          3.4            10.9
Noncontrolling
Interests
NET EARNINGS
ATTRIBUTABLE TO        $  162.2       $ 165.8      $  334.7       $ 330.0
SHAREHOLDERS
                                                                     
                                                                     
                                                                     
Earnings per Share*–
Basic
Net Earnings
Attributable to        $  0.80        $ 0.81       $  1.65        $ 1.61
Shareholders
Earnings per Share*–
Diluted
Net Earnings
Attributable to        $  0.80        $ 0.81       $  1.64        $ 1.61
Shareholders
                                                                     
Weighted-average       203.2           204.7         203.2           204.7
Shares – Diluted
Dividends Declared     $  0.34         $ 0.30        $  0.68         $ 0.60
per Share
                                                                       

*The numerator for basic and diluted earnings per share is net earnings
attributable to shareholders reduced by dividends and undistributed earnings
attributable to unvested shares. The denominator for basic earnings per share
is the weighted-average shares outstanding during the period. The denominator
for diluted earnings per share is the weighted-average shares outstanding
adjusted for the effect of dilutive stock options and performance share
awards.

                                                          
                                                             
MEAD JOHNSON NUTRITION COMPANY

CONSOLIDATED BALANCE SHEETS

(Dollars and shares in millions, except per share data)

(UNAUDITED)
                                                             
                                             June 30, 2013   December 31, 2012
ASSETS
CURRENT ASSETS:
Cash and Cash Equivalents                    $  1,003.9      $   1,042.1
Receivables – net of allowances of $6.4      384.4           364.6
and $7.6, respectively
Inventories                                  456.1           435.9
Deferred Income Taxes – net of valuation     82.6            86.4
allowance
Income Taxes Receivable                      46.9            26.0
Prepaid Expenses and Other Assets            71.6           60.0          
Total Current Assets                         2,045.5         2,015.0
Property, Plant, and Equipment – net         739.5           689.9
Goodwill                                     217.1           270.6
Other Intangible Assets – net                115.2           129.9
Deferred Income Taxes – net of valuation     32.7            24.5
allowance
Other Assets                                 128.8          128.3         
TOTAL                                        $  3,278.8     $   3,258.2   
LIABILITIES AND EQUITY/(DEFICIT)
CURRENT LIABILITIES:
Short-term Borrowings                        $  38.2         $   161.0
Accounts Payable                             522.6           508.5
Dividends Payable                            69.4            61.3
Note Payable                                 16.8            26.0
Accrued Expenses                             193.7           220.4
Accrued Rebates and Returns                  326.5           314.8
Deferred Income – current                    17.0            36.1
Income Taxes – payable and deferred          58.4           41.8          
Total Current Liabilities                    1,242.6         1,369.9
Long-Term Debt                               1,518.9         1,523.2
Deferred Income Taxes – noncurrent           19.6            15.9
Pension, Postretirement and Postemployment   185.1           188.8
Liabilities
Other Liabilities                            111.8          95.1          
Total Liabilities                            3,078.0         3,192.9
COMMITMENTS AND CONTINGENCIES
                                                             
REDEEMABLE NONCONTROLLING INTEREST           42.6            36.3
                                                             
EQUITY/(DEFICIT)
Shareholders’ Equity
Common Stock, $0.01 par value: 3,000
authorized, 206.7 and 206.0 issued,          2.1             2.1
respectively
Additional Paid-in/(Distributed) Capital     (638.9      )   (676.6        )
Retained Earnings                            1,305.6         1,124.8
Treasury Stock – at cost                     (305.2      )   (244.6        )
Accumulated Other Comprehensive Loss         (216.9      )   (187.0        )
Total Shareholders’ Equity/(Deficit)         146.7           18.7
Noncontrolling Interests                     11.5           10.3          
Total Equity/(Deficit)                       158.2          29.0          
TOTAL                                        $  3,278.8     $   3,258.2   
                                                                           
                                                                           
                                                                           

MEAD JOHNSON NUTRITION COMPANY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in millions)

(UNAUDITED)
                                                     
                                                       June 30,
                                                       2013         2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Earnings                                           $ 338.1       $ 340.9
Adjustments to Reconcile Net Earnings to Net Cash
Provided by Operating Activities:
Depreciation and Amortization                          41.7          37.6
Other                                                  46.8          29.9
Changes in Assets and Liabilities                      (23.9     )   (137.6  )
Pension and Other Postretirement Benefits              (2.9      )   (3.6    )
Contributions
Net Cash Provided by Operating Activities              399.8         267.2
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments for Capital Expenditures                      (117.0    )   (50.0   )
Proceeds from Sale of Property, Plant and Equipment    1.6           0.8
Investment in Other Companies                          (1.3      )   —
Acquisition                                            —            (106.1  )
Net Cash Used in Investing Activities                  (116.7    )   (155.3  )
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Short-term Borrowings                    5.3           180.0
Repayments of Short-term Borrowings                    (128.1    )   (180.0  )
Repayments of Notes Payable                            (10.8     )   —
Payments of Dividends                                  (129.9    )   (114.3  )
Stock-based-compensation-related Proceeds and Excess   18.8          18.8
Tax Benefits
Purchases of Treasury Stock                            (60.6     )   (58.8   )
Distributions to Noncontrolling Interests              (4.9      )   (2.2    )
Net Cash Used in Financing Activities                  (310.2    )   (156.5  )
Effects of Changes in Exchange Rates on Cash and       (11.1     )   (8.4    )
Cash Equivalents
NET DECREASE IN CASH AND CASH EQUIVALENTS              (38.2     )   (53.0   )
CASH AND CASH EQUIVALENTS:
Beginning of Period                                    1,042.1      840.3   
End of Period                                          $ 1,003.9    $ 787.3 
                                                                             
                                                                             
                                                                             

                        MEAD JOHNSON NUTRITION COMPANY
                      SUPPLEMENTAL FINANCIAL INFORMATION
                            (Dollars in millions)
                                 (UNAUDITED)

During the fourth quarter of 2012, the company implemented a change in its
organizational structure involving the transfer of its Puerto Rican operations
from North America to Latin America. This change did not impact Europe or Asia
and did not have a material impact on the assets of North America or Latin
America. Segment information, for all periods presented, has been revised to
be consistent with the new basis of presentation. See our fourth quarter 2012
Earnings Release for the revised results.

                                                                               
                 Three Months Ended June 30,                 % Change              % Change Due to
Net Sales        2013         % of   2012         % of    Reported  Constant   Volume  Price/Mix  Foreign
                               Total                 Total              Dollar                          Exchange
Asia/Latin       $ 757.4       72  %   $ 702.0       69  %   8    %     8    %     6   %    2    %      —    %
America
North            297.9        28  %   310.3        31  %   (4   )%    (4   )%    (6  )%   2    %      —    %
America/Europe
Net Sales        $ 1,055.3    100 %   $ 1,012.3    100 %   4    %     4    %     2   %    2    %      —    %
                                                                                                        
                                                                                                        
Earnings
Before                         EBIT                  EBIT
Interest and                   % of                  % of
Income Taxes                   Sales                 Sales
(EBIT)
Asia/Latin       $ 239.6       32  %   $ 239.9       34  %   —    %
America
North            73.4          25  %   72.2          23  %   2    %
America/Europe
Corporate and    (81.4     )   —   %   (63.8     )   —   %   (28  )%
Other
EBIT             $ 231.6      22  %   $ 248.3      25  %   (7   )%
                                                                                                        
                                                                                                        

                Six Months Ended June 30,                  % Change             % Change Due to
Net Sales        2013         % of   2012         % of    Reported  Constant   Volume  Price/Mix  Foreign
                               Total                 Total              Dollar                          Exchange
Asia/Latin       $ 1,512.7     72%     $ 1,409.3     71%     7    %     7    %     3   %    4    %      —    %
America
North            580.5        28%     589.6        29%     (2   )%    (2   )%    (5  )%   3    %      —    %
America/Europe
Net Sales        $ 2,093.2    100%    $ 1,998.9    100%    5    %     5    %     1   %    4    %      —    %
                                                                                                        
                                                                                                        
Earnings
Before                         EBIT                  EBIT
Interest and                   % of                  % of
Income Taxes                   Sales                 Sales
(EBIT)
Asia/Latin       $ 508.0       34%     $ 520.8       37%     (2   )%
America
North            124.7         21%     104.0         18%     20   %
America/Europe
Corporate and    (152.0    )   —%      (127.7    )   —%      (19  )%
Other
EBIT             $ 480.7      23%     $ 497.1      25%     (3   )%
                                                                                                        

Non-GAAP Financial Measures

This news release contains non-GAAP financial measures, including non-GAAP
EBIT, earnings and earnings per share information. Specified Items, listed in
the table below, are items included in GAAP measures, but excluded for the
purpose of determining non-GAAP EBIT, earnings and earnings per share.
Non-GAAP EBIT, earnings and earnings per share information adjusted for these
items is an indication of the company's underlying operating results and
intended to enhance an investor's overall understanding of the company's
financial performance. In addition, this information is among the primary
indicators the company uses as a basis for evaluating company performance,
setting incentive compensation targets, and planning and forecasting of future
periods. This information is not intended to be considered in isolation or as
a substitute for financial measures prepared in accordance with GAAP. Tables
that reconcile GAAP to non-GAAP disclosure follow:

                        MEAD JOHNSON NUTRITION COMPANY
                  RECONCILIATION OF GAAP TO NON-GAAP RESULTS
                 (Dollars in millions, except per share data)
                                 (UNAUDITED)

         Three Months ended June 30,
                 Earnings Before        Net Earnings           Earnings per
                 Interest                Attributable            Common
                 and Income Taxes        to Shareholders         Share - Diluted
                 2013       2012        2013       2012        2013      2012
GAAP Results     $ 231.6     $ 248.3     $ 162.2     $ 165.8     $ 0.80     $ 0.81
Specified
Items: ^ (1)
IT and other
separation       —           5.4
costs ^(2)
Severance and
other costs      0.6         0.5
^(3)
Legal,
settlements      7.4        1.4     
and related
costs ^(2,3)
Specified
Items before     8.0         7.3         8.0         7.3         0.04       0.03
income taxes
Income tax
impact on                                0.8        (1.9    )   —         —
items above
Non-GAAP         $ 239.6    $ 255.6    $ 171.0    $ 171.2    $ 0.84    $ 0.83
Results
                                                                              

         Six Months ended June 30,
                 Earnings Before        Net Earnings           Earnings per Common
                 Interest                Attributable
                 and Income Taxes        to Shareholders         Share - Diluted
                 2013       2012        2013       2012        2013      2012
GAAP Results     $ 480.7     $ 497.1     $ 334.7     $ 330.0     $ 1.64     $ 1.61
Specified
Items: ^ (1)
IT and other
separation       —           7.1
costs ^(2)
Severance and
other costs      2.0         1.5
^(3)
Legal,
settlements      7.6        2.9     
and related
costs ^(2,3)
Specified
Items before     9.6         11.5        9.6         11.5        0.05       0.05
income taxes
Income tax
impact on                                0.7        (2.9    )   —         (0.01  )
items above
Non-GAAP         $ 490.3    $ 508.6    $ 345.0    $ 338.6    $ 1.69    $ 1.65 
Results
                                                                                   

^(1) All Specified Items are included in the Corporate and Other segment
^(2) Included in Selling, General and Administrative expenses
^(3) Included in Other Expenses-net

Contact:

Mead Johnson Nutrition Company
Investors:
Kathy MacDonald, (847) 832-2182
kathy.macdonald@mjn.com
or
Media:
Christopher Perille, (847) 832-2178
chris.perille@mjn.com
 
Press spacebar to pause and continue. Press esc to stop.